ASO Author Reflections: Is Neoadjuvant Chemotherapy Associated with Acceptable Short-Term Outcomes for Pancreatic Cancer?

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{722e40ac65da439ebdbb4c43ee262e3a,

title = "ASO Author Reflections: Is Neoadjuvant Chemotherapy Associated with Acceptable Short-Term Outcomes for Pancreatic Cancer?",

author = "Kamarajah, \{Sivesh K.\} and Fadi Dahdaleh",

year = "2021",

month = apr,

doi = "10.1245/s10434-020-09472-9",

language = "English",

volume = "28",

pages = "1906--1907",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer",

number = "4",

}

TY - JOUR

T1 - ASO Author Reflections

T2 - Is Neoadjuvant Chemotherapy Associated with Acceptable Short-Term Outcomes for Pancreatic Cancer?

AU - Kamarajah, Sivesh K.

AU - Dahdaleh, Fadi

PY - 2021/4

Y1 - 2021/4

UR - https://www.scopus.com/pages/publications/85098753625

U2 - 10.1245/s10434-020-09472-9

DO - 10.1245/s10434-020-09472-9

M3 - Article

C2 - 33389290

SN - 1068-9265

VL - 28

SP - 1906

EP - 1907

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - 4

ER -